Recombinant Human Soluble Receptor for Advanced Glycation End Product Therapy Reduces Autoimmune Diabetes in the NOD Mouse Model

被引：0
|
作者：
Leung, Sherman
Borg, Danielle J.
Mccarthy, Domenica
Zhuang, Aowen
Forbes, Josephine
Ward, Micheal
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1831-P
引用
收藏
页码：A473 / A473
页数：1
相关论文
共 50 条
  • [31] Bridging advanced glycation end product, receptor for advanced glycation end product and nitric oxide with hormonal replacement/estrogen therapy in healthy versus diabetic postmenopausal women: A perspective
    Mukhopadhyay, S
    Mukherjee, TK
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2005, 1745 (02): : 145 - 155
  • [32] Soluble receptor for advanced glycation end products (sRAGE) attenuates haemodynamic changes to chronic hypoxia in the mouse
    Farmer, David G. S.
    Ewart, Marie-Ann
    Mair, Kirsty M.
    Kennedy, Simon
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 29 (01) : 7 - 14
  • [33] The receptor for advanced glycation end products is dispensable in a mouse model of oral and esophageal carcinogenesis
    Mark, Regina
    Bermejo, Justo Lorenzo
    Bierhaus, Angelika
    Plinkert, Peter K.
    Angel, Peter
    Hess, Jochen
    HISTOLOGY AND HISTOPATHOLOGY, 2013, 28 (12) : 1585 - 1594
  • [34] Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes
    Tan, K. C. B.
    Chow, W. S.
    Tso, A. W. K.
    Xu, A.
    Tse, H. F.
    Hoo, R. L. C.
    Betteridge, D. J.
    Lam, K. S. L.
    DIABETOLOGIA, 2007, 50 (09) : 1819 - 1825
  • [35] Skin Autofluorescence Relates to Soluble Receptor for Advanced Glycation End-Products and Albuminuria in Diabetes Mellitus
    Skrha, J., Jr.
    Soupal, J.
    Ekali, G. Loni
    Prazny, M.
    Kalousova, M.
    Kvasnicka, J.
    Landova, L.
    Zima, T.
    Skrha, J.
    JOURNAL OF DIABETES RESEARCH, 2013, 2013
  • [36] Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes
    K. C. B. Tan
    W. S. Chow
    A. W. K. Tso
    A. Xu
    H. F. Tse
    R. L. C. Hoo
    D. J. Betteridge
    K. S. L. Lam
    Diabetologia, 2007, 50 : 1819 - 1825
  • [37] ADVANCED GLYCATION END PRODUCTS AND THE SOLUBLE FORM OF THE AGE RECEPTOR IN PATIENTS WITH TYPE II DIABETES AND OSTEOARTHRITIS
    Thauerer, B.
    Kullich, W.
    Stritzinger, B.
    Kroell-Kalbhenn, A.
    Reimair, S.
    Salzer, A.
    Steinecker-Frohnwieser, B.
    OSTEOARTHRITIS AND CARTILAGE, 2022, 30 : S393 - S394
  • [38] Absence of Receptor for Advanced Glycation End Product (RAGE) Reduces Inflammation and Extends Survival in the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
    John D. Lee
    Tanya S. McDonald
    Jenny N. T. Fung
    Trent M. Woodruff
    Molecular Neurobiology, 2020, 57 : 4143 - 4155
  • [39] Absence of Receptor for Advanced Glycation End Product (RAGE) Reduces Inflammation and Extends Survival in the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
    Lee, John D.
    McDonald, Tanya S.
    Fung, Jenny N. T.
    Woodruff, Trent M.
    MOLECULAR NEUROBIOLOGY, 2020, 57 (10) : 4143 - 4155
  • [40] Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes
    Aubert, C. E.
    Michel, P. -L.
    Gillery, P.
    Jaisson, S.
    Fonfrede, M.
    Morel, F.
    Hartemann, A.
    Bourron, O.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 (08) : 679 - 685
12345